EFFECT OF FLAG REGIMEN IN TREATMENT OF CHILDREN WITH ACUTE REFRACTORY AND RELAPSED LEUKEMIA

被引：0
|
作者：
Lin, Y. [1 ]
机构：
[1] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Pediat Hematol Oncol, Guangzhou, Guangdong, Peoples R China
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：213 / 213
页数：1
相关论文
共 50 条
  • [1] OUTCOME OF FLAG REGIMEN IN THE TREATMENT OF REFRACTORY OR RELAPSED ADULT ACUTE MYLOID LEUKEMIA
    Alwan, F.
    Matti, F.
    Naji, S.
    Almudhaffar, J.
    HAEMATOLOGICA, 2012, 97 : 507 - 507
  • [2] FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies
    Mustafa, Omima
    Abdalla, Khalid
    AlAzmi, Aeshah A.
    Elimam, Naglla
    Abrar, Mohammed Burhan
    Jastaniah, Wasil
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (08) : 1831 - 1838
  • [3] Outcome Of Dose-Adjusted Decitabine Regimen Compared With FLAG Regimen In The Treatment Of Relapsed/Refractory Acute Myeloid Leukemia
    Wu, Qian
    He, Guangsheng
    Wu Depei
    Sun, Aining
    Qiu, Huiying
    Jin, Zhengming
    Miao, Miao
    Tang, XiaoWen
    Han, Yue
    Shen, Yiming
    Chen, Feng
    Hu, Xiaohui
    Jin, Song
    Zhang, Xuhui
    BLOOD, 2013, 122 (21)
  • [4] FLAG regimen with or without idarubicin in the treatment of refractory and relapsed acute myeloid leukemia: a single center experience
    Aljaber, Rana A.
    Abbasi, Salah
    Marei, Lina
    Dowairi, Mohammad
    Nazer, Lama H.
    PHARMACOTHERAPY, 2012, 32 (05): : E121 - E122
  • [5] Feasibility of FLAG-IDA regimen in cases with relapsed/refractory acute leukemia cases
    Paydas, S
    Yavuz, S
    Disel, U
    ANNALS OF HEMATOLOGY, 2006, 85 (01) : 63 - 63
  • [6] Feasibility of FLAG-IDA regimen in cases with relapsed/refractory acute leukemia cases
    Semra Paydas
    Sinan Yavuz
    Umut Disel
    Annals of Hematology, 2006, 85 : 63 - 63
  • [7] FLAG-IDA REGIMEN IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOBLASTIC LEUKEMIA: SINGLE-CENTER EXPERIENCE
    Genadieva-Stavrik, G.
    Georgievski, B.
    Cevreska, L.
    Karanfilski, O.
    Pivkova, A.
    Stojanoski, Z.
    Krstevska-Balkanov, S.
    Dukovski, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 560 - 561
  • [8] Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia.
    Meng, FY
    Yang, LJ
    Xu, B
    Liu, XL
    Zheng, WY
    Zhang, Y
    Fen, H
    Xu, D
    Sun, J
    Liu, QF
    BLOOD, 2003, 102 (11) : 244B - 244B
  • [9] FLAG Regimen with or without Idarubicin in Children with Relapsed/Refractory Acute Leukemia: Experience from a Turkish Pediatric Hematology Center
    Bengoa, Sebnem Yilmaz
    Ataseven, Eda
    Kizmazoglu, Deniz
    Yenigurbuz, Fatma Demir
    Erdem, Melek
    Oren, Hale
    TURKISH JOURNAL OF HEMATOLOGY, 2017, 34 (01) : 46 - 51
  • [10] FLAG-liposomal doxorubicin (Myocet) regimen for children with refractory or relapsed acute myeloid leukemia: A single centre experience
    Timeus, F.
    Quarello, P.
    Barisone, E.
    Vassallo, E.
    Fagioli, F.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S73 - S73
12345